Arranja A, Gouveia LF, Gener P, Rafael DF, Pereira C, Schwartz S Jr, Videira MA. Int J Pharmatech 2016 Feb 4. pii: S0378-5173(16)30075-8. http://www.sciencedirect.com/science/article/pii/S0378517316300758 Abstract In past years, a considerable...
Read moreCancer stem cells and personalized cancer nanomedicine
Gener P, Rafael DF, Fernandez Y, Ortega JS, Arango D, Abasolo I, Videira M, Schwartz S Jr. Nanomedicine (Lond) 2016 Feb; 11(3):307-20 https://www.ncbi.nlm.nih.gov/pubmed/26785724 Abstract Despite the progress in cancer treatment over the past...
Read moreDr Simó Schwartz Jr is appointed editor of the European Journal of Nanomedicine
Dr Simó Schwartz Jr, director of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VHIR), has been appointed member of the editorial board of the European Journal of Nanomedicine. VHIR’s researcher will review some of the...
Read moreMiniaturized metal oxide pH sensors for bacteria detection
N Uria, N Abramova, A Bratov, FX Muñoz-Pascual, E Baldrich Talanta, Volume 147, 15 January 2016, Pages 364–369 http://www.sciencedirect.com/science/article/pii/S0039914015303775 Abstract It is well known that the metabolic activity of...
Read moreDeveloping enhanced magneto-immunosensors based on low-cost screen-printed electrode devices
Z Herrasti, E de la Serna, G Ruiz-Vega, E Baldrich Developing enhanced magneto-immunosensors based on low-cost screen-printed electrode devices. Reviews in Analytical Chemistry, (2016) 35: 53–85. Artículo de revisión invitado...
Read moreThree VHIR researchers receive three important European grants
Dr. Simó Schwartz Jr, head of the CIBBIM-Nanomedicine Drug Delivery and Targeting group, Dr. Diego Arango, head of the CIBBIM-Nanomedicine Biomedical Research in Digestive Tumors group, and Dr. Mar Hernández-Guillamón, principal investigator of...
Read moreFluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
Gener P, Gouveia LP, Sabat GR, de Sousa Rafael DF, Fort NB, Arranja A, Fernández Y, Prieto RM, Ortega JS, Arango D, Abasolo I, Videira M, Schwartz S Jr. Nanomedicine. 2015 Nov;11(8):1883-92...
Read moreNew methodology to improve the drug response of breast and colon cancer with nanomedicine
Researchers from the Drug Delivery and Targeting group of the CIBBIM-Nanomedicine at Vall d’Hebron Institute of Research (VIHR), have evidenced that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells. To be...
Read moreBiological assessment of self-assembled polymeric micelles for pulmonary administration of insulin.
Andrade F, Neves Jd, Gener P, Schwartz S Jr, Ferreira D, Oliva M, Sarmento B. Nanomedicine-NBM. 2015 Oct;11(7):1621-31 https://www.ncbi.nlm.nih.gov/pubmed/26049134 Abstract Pulmonary delivery of drugs for both local and systemic action has...
Read moreVHIR inaugurates the 2nd edition of the Master’s Degree in Translational Biomedical Research
On September 29th, Vall d’Hebron Institute of Research (VHIR) celebrated the opening day of the 2nd edition of the Official Master’s Degree in Translational Biomedical Research and the closing of the 1st edition, with the diploma award ceremony...
Read moreVHIR receives two grants from the AECC to investigate stomach cancer and melanoma
The Vall d’Hebron Research Institute (VHIR) has received two projects in the last call of the Associación Española Contra el Cáncer (AECC) to investigate stomach cancer and malignant melanoma. The projects, worth 1,200,000 euros each, are...
Read moreImproving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center.
Pizzi MN, Roque A, Fernández-Hidalgo N, Cuéllar-Calabria H, Ferreira-González I, Gonzàlez-Alujas MT, Oristrell G, Gracia-Sánchez L, González JJ, Rodríguez-Palomares J, Galiñanes M, Maisterra-Santos O, Garcia-Dorado D, Castell-Conesa J, Almirante...
Read more
